Lianyun Huang
Research Subjects
Lianyun Huang has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Na Cai
Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland
6 shared publications - Kenneth S. Kendler
Virginia Institute for Psychiatric and Behavioral Genetics, Department of Psychiatry Virginia Commonwealth University Richmond Virginia USA
4 shared publications - Andrew Joseph Schork
Institute of Biological Psychiatry, Mental Health Centre, Sct. Hans, Copenhagen University Hospital, Roskilde, Denmark
3 shared publications - Jonathan Flint
Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, USA
3 shared publications - Andy Dahl
Section of Genetic Medicine, University of Chicago, Chicago, USA
2 shared publications - Federica Fermani
Department of Molecules – Signaling – Development, Max-Planck Institute for Biological Intelligence
2 shared publications
Latest Publications
- Open Access
Genetic risk effects on psychiatric disorders act in sets
Genetic studies of psychiatric disorders have typically assumed that all genetic effects contribute additively to disease liability. However, it is likely that psychiatric disorders have unrecognized subtypes, where synergistic sets of risk variants co-occur within certain cases more than expected under additivity. The existence of synergistic sets induces a structured form of statistical interactions called coordinated epistasis. We test for these interactions in five psychiatric disorders and find evidence for synergistic sets, and by extension, disorder subtypes. We further find that synergistic sets contributing to comorbidities are mostly disorder-specific, despite high genetic correlations between disorders, supporting current diagnostic distinctions between disorders. Finally, we find that genetic risk factors shared across disorders identify a cross-disorder subtype that is likely the result of heritable confounders, rather than disorder-specific etiology. Our results show that genetic risk effects for psychiatric disorders act in sets, implying the existence of subtypes, and re-interpret the importance of shared genetic effects in understanding disease biology and classification.
Open AccessGenetic risk effects on psychiatric disorders act in sets
Genetic studies of psychiatric disorders have typically assumed that all genetic effects contribute additively to disease liability. However, it is likely that psychiatric disorders have unrecognized subtypes, where synergistic sets of risk variants co-occur within certain cases more than expected under additivity. The existence of synergistic sets induces a structured form of statistical interactions called coordinated epistasis. We test for these interactions in five psychiatric disorders and find evidence for synergistic sets, and by extension, disorder subtypes. We further find that synergistic sets contributing to comorbidities are mostly disorder-specific, despite high genetic correlations between disorders, supporting current diagnostic distinctions between disorders. Finally, we find that genetic risk factors shared across disorders identify a cross-disorder subtype that is likely the result of heritable confounders, rather than disorder-specific etiology. Our results show that genetic risk effects for psychiatric disorders act in sets, implying the existence of subtypes, and re-interpret the importance of shared genetic effects in understanding disease biology and classification.
- Open Access
Molecular and neural mechanisms of behavioural integration in the extended-amygdala
Integration of diverse stimuli is crucial for organisms to adapt and communicate effectively, enabling overall homeostasis and survival. Studies have been performed on identifying specific neuronal encoding of individual behaviours, but how neurons integrate diverse behaviours across contexts remains elusive. Here we use Ca 2+ imaging in freely moving mice to identify neural ensembles in the extended amygdala encoding behaviours across six distinct contexts. We found extensive flexibility in these ensemble encodings that may act as reserves for behavioural integration, with those encoding aversive stimuli showing greater specificity. Finally, we identified differential gene expression profiles between ensembles that are enriched in associations with human psychiatric and neurodegenerative disorders. Overall, our results demonstrate the molecular mechanisms behind behavioural integration, and their potential implications in health and disease.
Open AccessMolecular and neural mechanisms of behavioural integration in the extended-amygdala
Integration of diverse stimuli is crucial for organisms to adapt and communicate effectively, enabling overall homeostasis and survival. Studies have been performed on identifying specific neuronal encoding of individual behaviours, but how neurons integrate diverse behaviours across contexts remains elusive. Here we use Ca 2+ imaging in freely moving mice to identify neural ensembles in the extended amygdala encoding behaviours across six distinct contexts. We found extensive flexibility in these ensemble encodings that may act as reserves for behavioural integration, with those encoding aversive stimuli showing greater specificity. Finally, we identified differential gene expression profiles between ensembles that are enriched in associations with human psychiatric and neurodegenerative disorders. Overall, our results demonstrate the molecular mechanisms behind behavioural integration, and their potential implications in health and disease.
- Open Access
- 20 November 2023
- Published by Springer Nature in Nature Genetics
- Vol. 55 (12) , 2269-2276
Deep learning-based phenotype imputation on population-scale biobank data increases genetic discoveries
Biobanks that collect deep phenotypic and genomic data across many individuals have emerged as a key resource in human genetics. However, phenotypes in biobanks are often missing across many individuals, limiting their utility. We propose AutoComplete, a deep learning-based imputation method to impute or ‘fill-in’ missing phenotypes in population-scale biobank datasets. When applied to collections of phenotypes measured across ~300,000 individuals from the UK Biobank, AutoComplete substantially improved imputation accuracy over existing methods. On three traits with notable amounts of missingness, we show that AutoComplete yields imputed phenotypes that are genetically similar to the originally observed phenotypes while increasing the effective sample size by about twofold on average. Further, genome-wide association analyses on the resulting imputed phenotypes led to a substantial increase in the number of associated loci. Our results demonstrate the utility of deep learning-based phenotype imputation to increase power for genetic discoveries in existing biobank datasets.
- 20 November 2023
- Published by Springer Nature in Nature Genetics
- Vol. 55 (12) , 2269-2276
Open AccessDeep learning-based phenotype imputation on population-scale biobank data increases genetic discoveries
Biobanks that collect deep phenotypic and genomic data across many individuals have emerged as a key resource in human genetics. However, phenotypes in biobanks are often missing across many individuals, limiting their utility. We propose AutoComplete, a deep learning-based imputation method to impute or ‘fill-in’ missing phenotypes in population-scale biobank datasets. When applied to collections of phenotypes measured across ~300,000 individuals from the UK Biobank, AutoComplete substantially improved imputation accuracy over existing methods. On three traits with notable amounts of missingness, we show that AutoComplete yields imputed phenotypes that are genetically similar to the originally observed phenotypes while increasing the effective sample size by about twofold on average. Further, genome-wide association analyses on the resulting imputed phenotypes led to a substantial increase in the number of associated loci. Our results demonstrate the utility of deep learning-based phenotype imputation to increase power for genetic discoveries in existing biobank datasets.
- Open Access
Polygenic analyses show important differences between MDD symptoms collected using PHQ9 and CIDI-SF
Symptoms of Major Depressive Disorder (MDD) are commonly assessed using self-rating instruments like the Patient Health Questionnaire 9 (PHQ9, for current symptoms), and the Composite International Diagnostic Interview Short-Form (CIDI-SF, for lifetime worst-episode symptoms). Using data from the UKBiobank, we show that corresponding symptoms endorsed through PHQ9 and CIDI-SF have low to moderate genetic correlations (rG=0.43-0.87), and this cannot be fully attributed to different severity thresholds or the use of a skip-structure in CIDI-SF. Through a combination of Mendelian Randomization (MR) and polygenic prediction analyses, we find that PHQ9 symptoms are more associated with traits which reflect general dysphoria, while the skip-structure in CIDI-SF allows for the identification of heterogeneity among likely MDD cases. This has important implications on factor analyses performed on their respective genetic covariance matrices for the purpose of identification of genetic factors behind MDD symptom dimensions and heterogeneity.
Open AccessPolygenic analyses show important differences between MDD symptoms collected using PHQ9 and CIDI-SF
Symptoms of Major Depressive Disorder (MDD) are commonly assessed using self-rating instruments like the Patient Health Questionnaire 9 (PHQ9, for current symptoms), and the Composite International Diagnostic Interview Short-Form (CIDI-SF, for lifetime worst-episode symptoms). Using data from the UKBiobank, we show that corresponding symptoms endorsed through PHQ9 and CIDI-SF have low to moderate genetic correlations (rG=0.43-0.87), and this cannot be fully attributed to different severity thresholds or the use of a skip-structure in CIDI-SF. Through a combination of Mendelian Randomization (MR) and polygenic prediction analyses, we find that PHQ9 symptoms are more associated with traits which reflect general dysphoria, while the skip-structure in CIDI-SF allows for the identification of heterogeneity among likely MDD cases. This has important implications on factor analyses performed on their respective genetic covariance matrices for the purpose of identification of genetic factors behind MDD symptom dimensions and heterogeneity.
- Open Access
- 16 November 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (46) , eabo1023
Tripartite extended amygdala–basal ganglia CRH circuit drives locomotor activation and avoidance behavior
An adaptive stress response involves various mediators and circuits orchestrating a complex interplay of physiological, emotional, and behavioral adjustments. We identified a population of corticotropin-releasing hormone (CRH) neurons in the lateral part of the interstitial nucleus of the anterior commissure (IPACL), a subdivision of the extended amygdala, which exclusively innervate the substantia nigra (SN). Specific stimulation of this circuit elicits hyperactivation of the hypothalamic-pituitary-adrenal axis, locomotor activation, and avoidance behavior contingent on CRH receptor type 1 (CRHR1) located at axon terminals in the SN, which originate from external globus pallidus (GPe) neurons. The neuronal activity prompting the observed behavior is shaped by IPACL CRH and GPe CRHR1 neurons coalescing in the SN. These results delineate a previously unidentified tripartite CRH circuit functionally connecting extended amygdala and basal ganglia nuclei to drive locomotor activation and avoidance behavior.
- 16 November 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (46) , eabo1023
Open AccessTripartite extended amygdala–basal ganglia CRH circuit drives locomotor activation and avoidance behavior
An adaptive stress response involves various mediators and circuits orchestrating a complex interplay of physiological, emotional, and behavioral adjustments. We identified a population of corticotropin-releasing hormone (CRH) neurons in the lateral part of the interstitial nucleus of the anterior commissure (IPACL), a subdivision of the extended amygdala, which exclusively innervate the substantia nigra (SN). Specific stimulation of this circuit elicits hyperactivation of the hypothalamic-pituitary-adrenal axis, locomotor activation, and avoidance behavior contingent on CRH receptor type 1 (CRHR1) located at axon terminals in the SN, which originate from external globus pallidus (GPe) neurons. The neuronal activity prompting the observed behavior is shaped by IPACL CRH and GPe CRHR1 neurons coalescing in the SN. These results delineate a previously unidentified tripartite CRH circuit functionally connecting extended amygdala and basal ganglia nuclei to drive locomotor activation and avoidance behavior.
- Open Access
Deep Learning-based Phenotype Imputation on Population-scale Biobank Data Increases Genetic Discoveries
Biobanks that collect deep phenotypic and genomic data across large numbers of individuals have emerged as a key resource for human genetic research. However, phenotypes acquired as part of Biobanks are often missing across many individuals, limiting the utility of these datasets. The ability to accurately impute or “fill-in” missing phenotypes is critical to harness the power of population-scale Biobank datasets. We propose AutoComplete, a deep learning-based imputation method which can accurately impute missing phenotypes in population-scale Biobank datasets. When applied to collections of phenotypes measured across ≈ 300K individuals from the UK Biobank, AutoComplete improved imputation accuracy over existing 2 methods (average improvement in r 2 of 18% for all phenotypes and 42% for binary phenotypes). We explored the utility of phenotype imputation for improving the power of genome-wide association studies (GWAS) by applying our method to a group of five clinically relevant traits with an average missigness rate of 83% (67% to 94%) leading to an an increase in effective sample size of ≈2-fold on average (0.5 to 3.3-fold across the phenotypes). GWAS on the resulting imputed phenotypes led to an increase in the total number of loci significantly associated to the traits from four to 129. Our results demonstrate the utility of deep-learning based imputation to increase power for genetic discoveries in existing biobank data sets.
Open AccessDeep Learning-based Phenotype Imputation on Population-scale Biobank Data Increases Genetic Discoveries
Biobanks that collect deep phenotypic and genomic data across large numbers of individuals have emerged as a key resource for human genetic research. However, phenotypes acquired as part of Biobanks are often missing across many individuals, limiting the utility of these datasets. The ability to accurately impute or “fill-in” missing phenotypes is critical to harness the power of population-scale Biobank datasets. We propose AutoComplete, a deep learning-based imputation method which can accurately impute missing phenotypes in population-scale Biobank datasets. When applied to collections of phenotypes measured across ≈ 300K individuals from the UK Biobank, AutoComplete improved imputation accuracy over existing 2 methods (average improvement in r 2 of 18% for all phenotypes and 42% for binary phenotypes). We explored the utility of phenotype imputation for improving the power of genome-wide association studies (GWAS) by applying our method to a group of five clinically relevant traits with an average missigness rate of 83% (67% to 94%) leading to an an increase in effective sample size of ≈2-fold on average (0.5 to 3.3-fold across the phenotypes). GWAS on the resulting imputed phenotypes led to an increase in the total number of loci significantly associated to the traits from four to 129. Our results demonstrate the utility of deep-learning based imputation to increase power for genetic discoveries in existing biobank data sets.